Apramycin, an aminocyclitol aminoglycoside, was rapidly bactericidal against Acinetobacter baumannii. In a neutropenic murine thigh infection model, treatment-associated A. baumannii CFU reduction of greater than 4-log10 per thigh was observed for all exposures for which AUC/MIC was greater than 50 and Cmax/MIC was 10 or higher. Based on these findings, we suggest that apramycin deserves further pre-clinical exploration as a repurposed therapeutic for the treatment of multidrug-resistant, Gram-negative pathogens including A. baumannii.
http://ift.tt/2rk0BUn
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου